AlloVir
Developing cellular immunotherapies for severe viral infections. Learn more
Launch date
Employees
Market cap
€78.9m
Enterprise valuation
(€31m) (Public information from Sep 2024)
Share price
$0.79 ALVR
Lincoln Massachusetts (HQ)
Authorizing premium user...